Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4630732 Target Snapshot

Protein cereblon/Serine/threonine-protein kinase WEE1 · PROTEIN-PROTEIN INTERACTION · Homo sapiens

43Compounds
55Assays
0Approved Drugs
20.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P30291. Use UniProt P30291 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30291 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein cereblon/Serine/threonine-protein kinase WEE1 as ChEMBL target CHEMBL4630732, mapped to UniProt P30291. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein cereblon/Serine/threonine-protein kinase WEE1
PROTEIN-PROTEIN INTERACTION · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4630732
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P30291
Wee1-like protein kinase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein cereblon/Serine/threonine-protein kinase WEE1 is the right protein anchor across sources, using UniProt P30291 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelWee1-like protein kinase
UniProt AccessionP30291
Component TypeProtein
Sequence Length646 aa

Wee1-like protein kinase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein cereblon/Serine/threonine-protein kinase WEE1, mapped to UniProt P30291. ChEMBL maps the protein component as Wee1-like protein kinase. Sequence length is 646 aa.

Mapped IDP30291
Review nameProtein cereblon/Serine/threonine-protein kinase WEE1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5019.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4638510 8.45 IC50 3.58 Preclinical
CHEMBL1976040 7.76 IC50 17.28 Clinical
CHEMBL5432090 7.25 IC50 56.88 Preclinical
CHEMBL5412009 7.12 IC50 75.33 Preclinical
CHEMBL5427326 7.11 IC50 78.57 Preclinical
CHEMBL5403604 7.1 IC50 79.47 Preclinical
CHEMBL5412194 7.06 IC50 86.73 Preclinical
CHEMBL4638510 7.0 EC50 100.0 Preclinical
CHEMBL5421561 6.86 IC50 138.05 Preclinical
CHEMBL5405576 6.84 IC50 142.75 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
1
5.5
5
6.0
5
6.5
6
7.0
1
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

55
Total Assays
20
Tested Compounds
1
Assay Types
Binding — 55 assays, 20 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 53 1 7.0
protein format 2 19 6.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine